Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma

PURPOSE: The renin-angiotensin system may play a role in carcinogenesis. The purpose of this study was to evaluate the impact of angiotensin system inhibitors (ASIs) on outcomes in metastatic renal cell carcinoma (mRCC) patients treated in the targeted therapy era. METHODS: We conducted a pooled ana...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: McKay, Rana R., Rodriguez, Gustavo E., Lin, Xun, Kaymakcalan, Marina D., Hamnvik, Ole-Petter R., Sabbisetti, Venkata S., Bhatt, Rupal S., Simantov, Ronit, Choueiri, Toni K.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4566854/
https://ncbi.nlm.nih.gov/pubmed/25724518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2332
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires